Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Differentiation of human embryonic stem cells

A cell differentiation and pluripotent stem cell technology, applied in the field of promoting pluripotent stem cell differentiation, can solve the problem of not completely simulating the developmental program of higher mammals

Active Publication Date: 2011-01-19
LIFESCAN INC
View PDF42 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] However, mouse models of embryonic stem cell development may not fully mimic the developmental program in higher mammals such as humans

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Differentiation of human embryonic stem cells
  • Differentiation of human embryonic stem cells
  • Differentiation of human embryonic stem cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0320] Human embryonic stem cell culture

[0321] Human embryonic stem cell lines H1, H7, and H9 were obtained from WiCell Research Institute, Inc., (Madison, WI) and cultured according to instructions provided by the source company. Briefly, cells were cultured on mouse embryonic fibroblast (MEF) feeder cells in ES cell medium supplemented with 20% knockout serum replacer, 100 nM MEM non-essential amino acids, 0.5 mM Beta-mercaptoethanol, DMEM / F12 (Invitrogen / GIBCO) composition with 4 ng / ml human basic fibroblast growth factor (bFGF) in 2 mM L-glutamine (all from Invitrogen / GIBCO). MEF cells derived from E13 to 13.5 mouse embryos were purchased from Charles River. MEF cells were expanded in DMEM medium supplemented with 10% FBS (Hyclone), 2 mM glutamine and 100 mM MEM non-essential amino acids. Subconfluent MEF cells were treated with 10 μg / ml mitomycin C (Sigma, St. Louis, MO) for 3 hours to arrest cell division, then treated with trypsin and incubated with 2 × 10 4 / cm...

example 2

[0323] Formation of definitive endoderm cells

[0324] The effect of activin A on markers of definitive endoderm was examined. Activin A (100 ng / ml) was added to human embryonic stem cell populations cultured on mouse embryonic fibroblasts. Cells were continuously cultured in the presence of Activin A and harvested at the indicated times. By PCR ( figure 1 ), FACS (results are summarized in Table II) and immunohistochemistry ( figure 2 ) to test the expression levels of definitive endoderm markers.

[0325] Activin A caused a time-dependent increase in the mRNA expression of CXCR4, GATA4, HNF-3β, Mixl1 and Sox-17 in the H9 line ( figure 1 , sub-figure a). Significant upregulation of the anterior endoderm markers Cerberus, Otx-1, and Hex genes was also observed ( figure 1 , sub-figure b). Increased CXCR4 protein was observed by FACS after treatment with Activin A. Expression of E-cadherin and N-cadherin was not altered after treatment with activin A (Table IIA). CXC...

example 3

[0327] Pancreatic endoderm cell formation

[0328] Growth factors known to induce differentiation of human embryonic stem cells into pancreatic endoderm are added to the cell culture. Specifically, activin A, bFGF and retinoic acid, known to induce pancreatic endoderm formation, were added to the cultures.

[0329] In an initial series of experiments, activin A was added to human embryonic fibroblasts cultured for up to seven days in DMEM / F12 supplemented with 0% to 2% serum and activin A (100 ng / ml). in embryonic stem cell populations. exist image 3 Cells were harvested at the time points indicated in and the expression of the indicated genes was determined by PCR ( image 3 , 4 and 5). exist image 3 Among them, PCR analysis showed that activin-treated cells expressed a broad spectrum of genes related to endoderm development, including GATA4( image 3 , sub-figure a), Sox-17 ( image 3 , sub-figure b), HNF-3β ( image 3 , sub-figure c) and Mixl-1( image 3 , sub...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides an improved method for the formation of pancreatic endoderm, pancreatic hormone expressing cells and pancreatic hormone secreting cells. The present invention also provides methods to promote the differentiation of pluripotent stem cells without the use of a feeder cell layer.

Description

technical field [0001] The present invention provides methods for promoting differentiation of pluripotent stem cells. In particular, the present invention provides improved methods for forming pancreatic endoderm, pancreatic hormone expressing cells, and pancreatic hormone secreting cells. The present invention also provides methods of promoting differentiation of pluripotent stem cells without the use of a feeder cell layer. Background technique [0002] Advances in cell replacement therapy for type I diabetes and the scarcity of transplantable islets have focused attention on developing a source of insulin-producing cells or beta cells suitable for engraftment. One approach is to generate functional beta cells from pluripotent stem cells, such as embryonic stem cells. [0003] In vertebrate embryonic development, pluripotent stem cells can give rise to a group of cells comprising the three germ layers (ectoderm, mesoderm and endoderm) in a process called gastrulation. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/06C12N5/071
CPCC12N2501/21C12N2500/34C12N2501/115C12N2501/23C12N2501/415C12N2501/16C12N2501/70C12N2501/155C12N2506/02C12N2533/90C12N2501/12C12N2501/385C12N2501/42C12N2501/335C12N5/0676C12N2501/999A61P3/10A61P7/12A61K35/39C12N2501/40
Inventor J·徐
Owner LIFESCAN INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com